Caller threatens to cut off union minister Anant kumar Hegde’s head

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru, Jul 6: Two fresh deaths in last 24 hours have taken the total number of covid-19 deaths in Dakshina Kannada district to 24.

The deceased are a 52-year-old woman from Ullal and a 52-year-old man from Thokkottu.

The man was suffering from cardovascular disease and pneumonia, sources said.

The woman passed away in Wenlock hospital.

More details are awaited.

Mangaluru, July 13: Dakshina Kannada district in-charge Minister Kota Srinivas Poojary on Monday said that all COVID-19 patients in the district will be treated for free in the hospitals of all medical colleges in the district.

Speaking to newsmen after visiting the COVID-19 treatment facility at KMC Hospital here, Poojary stated that all COVID-19 patients including BPL families, APL families, migrant workers and those without a ration card, will be treated free of charge in the district’s medical colleges. Patients can show their Aadhaar card at the hospital and get free treatment.

Provision of free treatment for COVID-19 patients at Wenlock hospital will be continued. In Dakshina Kannada district, the number of people recovering from the virus and being discharged hospitals is high. There is no need for the people of the district to panic. The government is committed to the health of the people, Poojary said.